Joaquin Borrás-Blasco

25PUBLICATIONS
11CO-AUTHORS
Disease surveillanceTraditional, complementary and integrative medicine not elsewhere classifiedGene and molecular therapyPharmacogenomicsVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 18, 2026
Remission and treatment persistence during sequential therapy in rheumatoid arthritis: results from the Estonian Biologic Treatment Registry.

|May 24, 2026
Letter to the editor regarding "Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice".

|Apr 29, 2026
Letter to the editor 'high persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study)'.

|Apr 28, 2026
Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety.

|Feb 16, 2026
Letter to the Editor Regarding 'National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort Study'.

Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo-Uixeda

|Jan 19, 2026
Letter to the Editor "Use and Persistence of Beta 3-Adrenoceptor Agonists for the Treatment of Overactive Bladder".

Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo-Uixeda

Pageof 5

Frequent Collaborators

4 joint publications

Alejandro Valcuende-Rosique

4 joint publications

Silvia Cornejo-Uixeda

1 joint publications

Tarek Carlos Salman-Monte

1 joint publications

Paloma Vela-Casasempere